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Abstract
Background: Particles in smaller size fractions, such as ultrafine particles (UFPs) (with diameter less than 100 nm), has
become of significant cardiovascular health concerns. However, the biological plausibility underlying potential
relationship between UFPs and cardiovascular outcomes is less studied.
Methods: Fifty-three subjects living in Shanghai with type-2 diabetes (T2D) or impaired glucose tolerance (IGT) were
followed for autonomic dysfunctions with three repeated measurements in 2010. Minute-to-minute concentrations of
ambient particles in small size-fractions (5-560 nm), black carbon (BC), sulfur dioxide (SO2), nitrogen dioxide (NO2),
carbon monoxide (CO), and ozone (O3) were monitored using a central monitoring laboratory equipped with
real-time air monitors close to residential area of the subjects. Generalized linear mixed models, with adjustment for
individual risk factors, were applied to assess the effects of air pollution on autonomic dysfunctions in subjects.
Results: Our study showed that significant reduction in the standard deviation of all NN intervals (SDNN) ranging
from 3.4% to 8.1% were associated with interquartile range (IQR) increase of number concentration of particles (PNC)
in size fractions <100 nm, and reduction from 1.3% to 4.6% with particles of diameter 100-200 nm, in subjects with
diabetes or glucose tolerance. Increased exposure to traffic-related pollutants BC, NO2 and CO, and combustion
pollutant SO2, were also significantly associated with HRV reductions. However, no effect was observed for particles in
size fraction of 200-560 nm and O3. Diabetic risk factor and gender appeared to have significant interactions on
autonomic dysfunction associated with UFPs and traffic pollution exposures in certain time-window.
Conclusions: Our results suggest that underlying diabetes or impaired glucose tolerance may confer reduced
autonomic function of heart due to traffic pollution exposure.
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tolerance
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Background
Association between particulate matter, with diameter
less than 10 and 2.5 μm (PM10 and PM2.5), and cardio-
vascular diseases (CVD) has been supported by numerous
epidemiologic studies [1]. Particles in smaller size frac-
tions, such as ultrafine particles (UFPs) (with diameter
less than 100 nm), have have been reported that may
contribute to increasing cardiovascular morbidity [2-4].
Particles emitted from transportation and industry com-
bustion have been found dominating the number and
surface concentrations of ambient particulate matters in
small size fractions [4-6], and carrying large amount of
adsorbed or condensed toxic air pollutants (oxidant gases,
organic compounds, and transition metals) [7]. Studies
reported that UFPs can potentially lead to acute cardio-
vascular responses [8-11]. However, compared to ambient
PM2.5 and PM10, underlying biological plausibility of rela-
tionship between UFPs and cardiovascular morbidity has
been far less studied.
Epidemiologic study findings suggested altered heart
rate variability (HRV) as a possible mechanism link-
ing ambient PM exposure to coronary heart disease
events in subjects with preexisting cardiometabolic dis-
eases [12-16]. Reduced HRV has been found associated
with increasing risk of first cardiovascular event in pop-
ulation without known cardiovascular diseases [17], and
associated with the development of coronary heart dis-
ease in individuals with diabetes [18]. The reduction of
HRV derived from electrocardiographic (ECG) monitor
recordings were found inversely associated with exposure
to ambient PM originated from traffic and combustion
sources [19,20]. Recent studies also reported the associ-
ations between HRV reduction and exposure to particles
in smaller size including UFPs and particles in accumu-
lation mode (with diameter less than 1 μm) [21,22], and
among persons with cardiometabolic diseases or with
metabolic syndromes [12,13,23,24]. However, the suscep-
tibility of persons with cardiometabolic disease to the
adverse effects of particulate matter is still uncertain,
despite being biologically plausible.
Because of the increasing prevalence of diabetes and its
association with an increasing risk of CVD, it is important
to determine whether diabetes or impaired glucose tol-
erance may modify PM-HRV association. Some evidence
suggests that ambient particles in small size fractions may
play an important role in previously reported associations
between traffic exposure and acute cardiovascular effects
[4,25,26]. In this study, we assessed the role of exposure
to particles in small size fractions 5-560 nm and black
carbon (as a proxy for traffic related pollutant exposure)
as cardiovascular risk factors in a group of subjects with
diabetes or impaired glucose tolerance. We further exam-
ined if the association would bemodified by diabetic state,
obesity and gender.
Results and discussion
Results
The demographic and clinical characteristics of our study
subjects are summarized in Table 1. The age of subjects
ranged from 51 to 68 years old. There was no signifi-
cant difference in gender ratio between type-2 diabetes
(T2D) and impaired glucose tolerance (IGT) groups, or
between obese and non-obese groups (p > 0.1). No sub-
ject had severe cardiovascular diseases, except 68% of the
subjects were with mild hypertension. All subjects with
T2D were on regular medications (i.e. biguanides or sul-
fonylureas), and/or with insulin treatment; however, the
subjects with IGT did not take regular medication, except
one subject was taking biguanides regularly controlling for
blood glucose level.
Summary statistics of particle number concentrations
(PNC) in six aggregated size fractions, BC, gaseous pol-
lutants, and meteorologic parameters are summarized in
Table 2. Within all the size fractions of particles, which
are those of diameters from 5 nm to 560 nm, particles of
size less than 200 nm dominated the number concentra-
tion, and ones of size 50-560 nm contributed the most of
the surface concentration and the mass concentration (see
Additional file 1).
All metrics of concentrations of particles in the size frac-
tion 50-100 nm and 100-200 nm were highly correlated
with BC, NO2, and CO with correlation coefficients rang-
ing from 0.55 to 0.78 (Table 3 and Additional file 1). The
total number and surface area concentrations of particles
were also highly correlated with BC and NO2. Particles in
all size fractions of measurement were inversely correlated
with O3, temperature and relative humidity (RH).
Table 1 Demographic characteristics for IGT and T2D
subjects
IGT T2D
Number 17 36
Age (year) 60.1 (1.0) 59.7 (0.6)
BMI (kg/m2) 25.3 (0.7) 26.7 (0.7)
Gender (Female/Male) 10/7 17/19
Weight (kg) 69.0 (1.8) 73.4 (2.0)
Height (cm) 165.2 (1.4) 165.4 (1.1)
Waist (cm) 92.2 (2.7) 92.8 (1.7)
Hip circumference (cm) 101.0 (2.0) 100.6 (1.3)
Waist/hip circumference 0.91 (0.01) 0.92 (0.01)
SDNN (ms) 119.6 (7.5) 108.6 (4.4)
rMSSD (ms) 23.8 (3.2) 19.8 (0.9)
LF (ms2) 305.2 (62.5) 263.7 (25.5)
HF (ms2) 160.7 (62.0) 95.9 (10.2)
Hypertension 8 28
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Table 2 Summary statistics of exposure andmeteorologic
parameters
Mean (SD)
PNC5−560 (1/cm3) 20220 (11489)
PNC5−10 (1/cm3) 1378 (1688)
PNC10−20 (1/cm3) 4032 (4087)
PNC20−50 (1/cm3) 6276 (4603)
PNC50−100 (1/cm3) 5074 (2858)
PNC100−200 (1/cm3) 2544 (1675)
PNC200−560 (1/cm3) 272 (238)
BC (μg/m3) 4.09 (2.37)
NO2 (ppb) 32.52 (16.89)
CO (ppm) 0.61 (0.33)
SO2 (ppb) 6.53 (5.28)
O3 (ppb) 25.83 (18.7)
Temperature (◦C) 22.62 (6.18)
RH (%) 67.86 (12.54)
Air pressure (bar) 1013.96 (6.42)
SD for standard deviation and IQR for interquatile range. The observations of all
the pollutants and meteorologic parameters were obtained in 1 minute interval
covering the whole period of each visit in April, June and September.
In Figure 1, we presented the adjusted percent changes
of standard deviation of all NN intervals (SDNN) per
interquartile range (IQR) increase of number concentra-
tions of particles in all size fractions, BC, and gaseous
pollutants in various time windows of pollutant expo-
sure, controlling age, gender, body mass index (BMI), time
of day, day of week, temperature, RH and visit. Greater
reductions in SDNN were associated with increase in
exposure to particles in smaller size fractions <100 nm,
followed by particles in 100-200 nm. Increased exposure
to traffic-related pollutants BC, NO2 and CO, and com-
bustion pollutant SO2, were also significantly associated
with SDNN reductions. Overall, the inverse associations
were the strongest for 4-hour average air pollutants expo-
sure. No effect was observed for particles in size fraction
of 200-560 nm and O3. Similar association patterns are
observed for other HRV measures, including the root
mean square of successive differences between adjacent
normal cycles (rMSSD), low frequency (LF) (0.04-0.15 Hz)
and high frequency (HF) (0.15-0.4 Hz), whereas the mag-
nitude of reduction for frequency-domain measure LF
and HF were greater (see Additional file 2).
To control the confounding effects of highly corre-
lated pollutants, we compared the estimated effects of
prior 4-hour average exposure to all size-fractioned par-
ticles, BC, O3, and NO2 in single- and two-pollutant
models (Table 4). In two-pollutant models with adjust-
ment for BC, the magnitude of effect estimates remained
similar for number concentrations of particles of size
10 to 20 nm (PNC10−20), NO2, and CO as the magni-
tude in single-pollutant models. The magnitude of effects
was reduced for PNC20−50, PNC50−100 and PNC5−560,
whereas the effects became insignificant for PNC100−200
and PNC200−560. With adjustment for BC, the associa-
tions with surface area concentrations of particles (PSC),
and mass concentrations of particles (PMC), remained
significant for particles in size-fraction 10-20 nm and 20-
50 nm only. In two-pollutant models with adjustment for
NO2, the associations between SDNN and all measured
pollutants, except BC, remained robust and consistent as
assessed in single-pollutant models. We did not observe
confounding effects of exposure to O3(results summa-
rized in Additional file 3).
Between subjects with T2D and in prediabetic state with
IGT, effects assessed at 4- and 24-hour average exposure
were presented in Figures 2 and 3. For prior 4-hour aver-
age air pollution exposure, we did not observe significant
heterogeneity in effect estimates (with p values for inter-
action >0.05); however, effects in subjects with IGT were
significantly stronger with prior 24-hour average exposure
(with p values for interaction <0.05).
Figure 4 shows the interaction effect of obesity on asso-
ciations between SDNN and 4-hour average of air pollu-
tion exposure. Subjects with BMI>25 kg/m2 were found
of greater SDNN reduction associated with exposure to
air pollution, and the risk was even higher in subjects
with BMI>28 kg/m2 (with p values for interaction <0.05).
However, we did not find significant interaction of central
Table 3 Correlations between number concentration of particles in each size fraction, and BC, gaseous pollutants and
meteorologic parameters
BC NO2 CO SO2 O3 T RH Air pressure
PNC5−560 0.52 0.65* 0.45 0.48 -0.1 -0.13 -0.14 0.18
PNC5−10 -0.06 0.16 -0.05 0.09 0.08 -0.2 -0.15 0.34
PNC10−20 0.13 0.35 0.08 0.1 0.02 -0.08 -0.19 0.25
PNC20−50 0.35 0.54 0.36 0.38 -0.14 -0.04 -0.14 0.21
PNC50−100 0.75* 0.78* 0.65* 0.58 -0.28 -0.12 -0.07 0.04
PNC100−200 0.72* 0.7* 0.56 0.6* -0.07 -0.2 -0.09 0.15
PNC200−560 0.37 0.36 0.3 0.31 -0.05 -0.19 0 0.18
T for temperature and * indicates correlation coefficients >0.6.
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Figure 1 Results of single-pollutant mixed-effects model. It shows the changes in SDNN per IQR increase in different proceeding moving average
exposures to ambient pollutants in the single-pollutant mixed-effects model.
adiposity in female nor in male subjects, though subjects
with lower waist to hip ratio appeared in greater SDNN
reduction associated with exposure to air pollution (with p
values for interaction >0.05, data in Additional file 4). The
correlation coefficients between obesity index BMI and
central adiposity index waist to hip ratio (WHr) ranged
0.27 to 0.45 in our subjects.
In the regression analyses of 4-hour average exposure
stratified by gender, with controlling for same covariates
in main models, we observed significant heterogeneity of
gender (with p values for interaction <0.05) (Figure 5). Per
IQR increase in 4-hour average of PNC5−560 (10,300 cm3),
we observed -12.0% (95% CI, -14.1% to -9.8%) in SDNN
in female, and -4.2% (95% CI, -6.4% to -1.9%) in
male, with p value for interactions <0.05. The modi-
fiction effect of gender were significant when exposure
to particles in size fraction <200 nm, NO2, SO2, or
CO was considered, and marginally significant on BC
exposure.
Discussion
In our study, we observed significant inverse associations
between autonomic dysfunctions in subjects with diabetes
Table 4 Percent change in SDNN per IQR increases in proceeding 4-hour moving average exposures to ambient
pollutants estimated in single-, and two-pollutant mixed-effects models
Single-pollutant Two-pollutant
Adj. for BC Adj. for NO2 Adj. for O3 Adj. for CO
BC -6.14 (-8.12,-4.11) -6.14 (-8.12,-4.12) 1.09 (-1.72,3.98) -5.18 (-7.31,-3) 0.07 (-2.7,2.91)
NO2 -8.98 (-10.72,-7.18) -9.56 (-11.85,-7.2) -8.97 (-10.72,-7.18) -9.33 (-11.34,-7.27) -6.43 (-8.64,-4.17)
CO -7.33 (-8.91,-5.73) -7.37 (-9.43,-5.25) -7.05 (-8.95,-5.11) -6.68 (-8.52,-4.81) -4.22 (-6.19,-2.21)
SO2 -4.36 (-5.85,-2.86) -2.91 (-4.66,-1.13) -0.56 (-2.38,1.30) -3.24 (-4.83,-1.62) -1.25 (-3.02,0.55)
O3 1.55 (-0.13,3.27) 0.51 (-1.22,2.27) 1.55 (-0.14,3.28) 0.94 (-0.77,2.68) -1.73 (-3.51,0.09)
PNC5−560 -7.89 (-9.69,-6.07) -6.82 (-8.87,-4.72) -7.73 (-9.57,-5.85) -7.47 (-9.65,-5.24) -4.54 (-6.82,-2.21)
PNC10−20 -7.0 (-8.88,-5.08) -7.05 (-8.92,-5.14) -7.21 (-9.14,-5.24) -6.73 (-8.65,-4.77) -6.18 (-8.1,-4.21)
PNC20−50 -6.57 (-8.07,-5.04) -5.77 (-7.34,-4.17) -6.36 (-7.92,-4.77) -6.07 (-7.77,-4.33) -4.32 (-6.07,-2.53)
PNC50−100 -5.37 (-7.34,-3.35) -2.76 (-5.29,-0.16) -5.65 (-7.69,-3.56) -3.49 (-6.03,-0.89) 1.52 (-1.32,4.45)
PNC100−200 -2.98 (-4.63,-1.3) 2.53 (-0.29,5.42) -2.53 (-4.26,-0.77) 0.3 (-1.84,2.49) 2.83 (0.71,4.99)
PNC200−560 -0.45 (-2.43,1.56) 5.15 (2.53,7.84) 0.09 (-1.96,2.18) 3.25 (0.97,5.59) 4.46 (2.22,6.75)
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Figure 2 Stratified analysis by diabetic states. It shows estimates for adjusted percent changes in SDNN per IQR increase in 4-hour average
exposures to different air pollutants in IGT and T2D groups.
and impaired glucose tolerance and exposure to ambi-
ent particles in small size fractions (diameter less than
200 nm), BC, NO2 (traffic pollution proxy) and CO. The
associations were stronger in subjects with obesity and in
female. However, the interaction effect of diabetic states
was not consistent over different averaging hours. Our
findings suggest that possible cardiovascular effects asso-
ciated with traffic pollution exposure may be mediated, in
part, through altered autonomic function, among persons
with diabetes or impaired glucose tolerance. Our findings
have broad clinical and public health implications for air
pollution induced cardiometabolic risks.
UFPs are an important component of combustion-
related or secondary aerosol-related air pollution with
large amount of toxic air pollutants and chemicals
adsorbed on its surfaces. With its high lung deposi-
tion efficiency in the lungs, UFPs can enter into pul-
monary interstitial sites and through circulation system
Figure 3 Stratified analysis by diabetic states. It shows estimates for adjusted percent changes in SDNN per IQR increase in 24-hour average
exposures to different air pollutants in IGT and T2D groups.
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Figure 4 Stratified analysis by obesity. It shows estimates for adjusted percent changes in SDNN per IQR increase in 4-hour average exposures to
different air pollutants in three groups stratified based on BMI.
reaching other target sites. The hypothesized interme-
diary pathophysiologic pathways associated with UFP
exposures include release of proinflammatory mediators
or vasculoactive molecules from lung-based cells, per-
turbation of systemic autonomic nerve system balance
or heart rhythm, and potentially translocation of PM or
PM constituents into circulation system [27]. Thus, we
focused on examining cardiovascular risk associated with
exposure to particles in small size fractions (between 5
to 560 nm) including UFPs, and traffic pollution mark-
ers (BC, NO2, and CO). Our overall results support
the hypothesis that greater cardiovascular responses are
associated with UFPs than with larger particles, and
are consistent with findings of autonomic, vascular and
Figure 5 Stratified analysis by gender. It shows estimates for adjusted percent changes in SDNN per IQR increase in 4-hour average exposures to
different air pollutants in male and female groups.
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thrombotic effects of UFPs inhalation observed in suscep-
tible and healthy subjects [21,22,25,28,29].
However, the associations between UFPs exposures and
acute changes in HRV reported in previous studies are not
consistent and the directions and magnitudes of the asso-
ciations varied across study locations. Chan et al. reported
significant inverse relationship between hours prior aver-
age UFP exposures in HRV in a panel of healthy and
elderly patients, with stronger effects in elderly subjects
in Taiwan [30]. Weichenthal et al. reported significant
reduction in HF and the proportion of NN50 divided by
total number of NNs (pNN50) within hours immediately
following UFP exposures in healthy cyclists in traffic in
Ottawa, Canada [21].
Park et al. observed inverse association between ambi-
ent UFP exposures over 48-hour moving averages and
HRV in elderly male subjects in Boston, USA, though the
associations were not statistically significant [23].
In more recent studies, Schneider et al. did not observe
significant associations between fixed-site ambient UFP
measures and HRV over up to 47 lag hours in elderly
men with coronary artery disease in Erfurt, Germany
[14]; whereas Rich et al. reported decreased rMSSD asso-
ciated with UFP exposures at significant level, but not
with particles in accumulation mode (100-500 nm) and
PM2.5, in a cardiac panel in rehabilitation in Rochester,
USA [22]. Vora et al. lately reported that inhalation of
elemental carbon ultrafine particles can alter heart rate
and HRV in subjects with T2D [31]. It is possible that
other pathophysiological factors such as activation of the
renin-angiotensin system, oxidative stress, and inflamma-
tory status in subjects with cardiovascular morbidities
may havemodulated the association between air pollution
exposure and autonomic nervous system dysfunction.
Pathophysiologically, autonomic nervous system dys-
function also relates to insulin resistance [32,33], and
abnormal glucose metabolism [34,35]. Park et al. reported
significant HRV reduction in subjects with metabolic syn-
drome associated with exposure to 2-day average PM2.5
in six US communities in the Multi-Ethnic Study of
Atherosclerosis (MESA) study, whereas no significant
change was found among subjects without metabolic
syndrome [13]. Whitsel et al. observed stronger inverse
PM10-HRV associations in subjects with diabetes, and
diabetic subjects of higher insulin and insulin resistance
level were of statistically greater HRV reduction [12].
Recently, Min et al. observed a significant reduction in
HRV related to exposure to carbonmonoxide (CO) among
persons with metabolic syndrome but not among per-
sons without metabolic syndrome [36]. In our analysis, we
examined the roles of diabetic state in modifying auto-
nomic dysfunctions associated with ambient pollution.
We observed significantly stronger inverse associations
with 24-hour prior exposure to UFPs and traffic pollutants
in subjects with IGT who did not receive regular medica-
tion to control for glucose level, but not in T2D subjects.
However, with 4-hour prior exposure, the interaction of
diabetic state between subjects with T2D and with IGT
was not significant. The differential responses observed
may be partially explained by insulin resistance or glucose
metabolism altered by medication use in subjects.
As an important risk factors of metabolic syndrome,
obesity is closely correlated with increased systemic
inflammation and oxidative stress that are cardiovascular
risk factors [37,38]. There is a growing body of evidence
that T2D is a chronic inflammatory state aggravated by
factors that promote inflammation at the level of vascu-
lature and adipose tissue [39,40], and increased oxidative
stress to adipocytes is central to the pathogenesis of car-
diovascular disease inmetabolic syndrome [41]. Air pollu-
tion may also promote T2D by increasing adipose inflam-
mation and insulin resistance. Sun et al. recently found
that PM2.5 exposure exaggerates whole-body insulin resis-
tance and adiposity inflammation in mice [42]. Consis-
tent with previous studies [20,24], obesity modified air
pollution attributed cardiac autonomic function in our
subjects. However, we did not observe interaction of
abdominal fat accumulation. It seems plausible to hypoth-
esize that adipose tissues located at different sites of body
may have different metabolic properties in predisposing
reduced skeletal muscle glucose utilization and insulin
resistance, thus to pose differential mechanisms in regu-
lation and/or impairments in sympathetic nervous system
function associated with air pollution exposure.
Previous research suggested that gender could mod-
ify the cardiovascular risk and air pollution associations;
however, the findings are heterogeneous [43,44]. Recent
studies reported higher traffic pollution associated with
cardiometabolic risks in females. Brook et al. found an
association between modeled NO2 exposure and T2D
prevalence among female patients, but not among male
patients, of two respiratory health clinics in Canada [45].
A study by Kramer et al. supported the plausibility of
oxidative stress and inflammation as a biological mecha-
nism for the relation between air pollution and T2D, by
showing that females with high C3c blood levels (a marker
for subclinical inflammation) were more susceptible for
particulate matter related excess risk of diabetes than
were females with low C3c levels. This prospective study
furthermore found a relation between traffic-related par-
ticulate matter and incident T2D among elderly women in
Germany [46]. In addition, an American study found an
association with distance to road among women, while no
strong evidence of an association with particulate matter
exposure was observed [47]. Consistent with our pre-
vious analysis [20], we observed greater HRV declines
associated with exposures to traffic-related pollutants BC
and gaseous pollutants in female elderly Chinese. Yet the
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prevalence of obesity and distribution of adipose tissue
differ by age and gender which could modify cardiac
responses pathophysiologically, the mechanisms for age,
obesity and gender specific interactions of air pollution
associated cardiovascular effects are not yet clear and
deserve further investigation.
Several study limitations should also be noted in inter-
preting our findings. First, we only investigated subjects
with T2D and IGT, and had no normal glucose tolerant or
lean control subjects. Second, we did not collect individual
data, such as insulin level and insulin resistance, home-
ostasis, systemic inflammation and oxidative stress, which
might have limited our capability further examining the
biological plausibility of diabetes in modifying UFPs and
traffic pollution associated cardiovascular dysfunctions.
Third, the fixed-location monitoring data was used in this
study, and the lack of information on personal exposure to
ambient pollutionmay have resulted in potential exposure
misclassification errors and may have biased the effect
estimates toward null. Fourth, we did not control subjects’
activity during observation, which may affect the results
of frequency-domain measurement of HRV. And lastly,
we did not obtain real-time minute-to-minute PM2.5 con-
centrations due to operational errors of the monitoring
instruments installed in the monitoring laboratory. Thus
we were not able to examine the commonly studied asso-
ciations between autonomic dysfunction and exposure to
criteria pollutant PM2.5, which has limited the generaliza-
tion of our results in broader context of adverse effects of
ambient fine particulates.
In summary, we observed autonomic dysfunction asso-
ciated with increased exposure to ambient UFPs and
traffic-related pollutants in previous hours among persons
with diabetes or impaired glucose tolerance, and the mag-
nitude of estimated effects were significantly stronger in
obese persons and in females. Our results suggest that
underlying metabolic condition may confer susceptibility
of traffic pollution on the heart.
Materials andmethods
Study design and subjects
This panel study was conducted in April, June and
September of 2010. We recruited 53 elderly subjects with
diagnosed type-2 diabetes or impaired glucose tolerance
through an existing diabetes cohort followed by Luwan
District Center for Disease Control (CDC) and Preven-
tion in Shanghai. The diabetes cohort was designed to
allow randomized or controlled evaluation of behavior
and dietary modification on progression and risk factors
of T2D. Since 2004, this cohort has enrolled approximately
4,000 individuals with diagnosed T2D or at risk, but free
of clinically apparent cardiovascular diseases at baseline
examination. At the enrollment, the disease state of each
individual was identified by standardized medical record
review and physician adjudication. During the follow-up,
fasting plasma samples were measured every six months.
All the subjects were retired elderly living within one
kilometer from Luwan CDC in central Shanghai. The
information on subjects’ age, gender, weight, height,
smoking status and medical history was obtained through
administered baseline questionnaire interview during
recruitment process. Our subjects received three repeated
measurements of 24-hour ambulatory ECG during study
period. The Institutional Review Board of Peking Uni-
versity Health Science Center approved study protocol
and written consent form. Informed consent was obtained
from each participant before the study participation.
Individual metabolic abnormality measurement
Our subjects had fasting blood samples drawn and mea-
sured for plasma glucose, gycosylated hemoglobin, triglyc-
eride, and cholesterol in routine follow-up in April and
October in 2010. Each participant was scheduled arriving
the check-up room in Luwan CDC at the same time of a
weekdaymorning for all visits. At each visit, technical staff
measured body weight, height, waist and hip circumfer-
ences, and blood pressure of each subject, and recorded
24-hour activity of the subjects prior to the visit through
questionnaire survey. We used clinical cutoff points for
diabetic states: T2D was defined as fasting blood glucose
≥ 126 mg/dL.
HRVmeasures
After physical examination at each visit, trained personnel
placed 7 bipolar leads of a ECG monitor on the par-
ticipant, following standard protocol. HRV were derived
from 24-h ECG recordings of subjects, under normal daily
activity conditions, using a 3-channel Holter monitoring
system (Model MGY H7, DM Software Inc., USA).
The ECG digital recordings were reviewed and pro-
cessed by trained cardiologists. Mean heart rate and var-
ious measure of HRV were calculated for each 24-Hour
session using PC-based software (Holter System Version
12.Net for Windows, DM Software). Each 5-minute seg-
ment of normal to normal intervals of the heart beat
was used to calculate the HRV index that included time-
domain measurements of SDNN and rMSSD, as well as
frequency-domain measurements of LF and HF.
Air pollution measures
Air pollution concentrations and meteorological data
weremonitored continuously using instruments equipped
in a laboratory in Luwan CDC. The repeatability, accu-
racy, and predictive validity of the air pollution measure-
ments conducted by the laboratory have been described
previously [48].
Minute-to-minute number concentration of particles
in size between 5 to 560 nm was monitored by a Fast
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Mobility Particle Sizer Spectrometer (FMPS Model 3091,
Thermo, USA). Number-size distributions were con-
verted to particle number concentrations, particle surface
area concentrations, and particle mass concentrations,
assuming spherical particles and 1 g/cm3 as default den-
sity parameter. In this analyses, we calculated 5-minute
mean concentration for particles in 5-10 nm, 10-20 nm,
20-50 nm, 50-100 nm, 100-200 nm, 200-560 nm size
fractions. Total number, surface, and area concentrations
of particles were computed as the sum of all fractions
(5-560 nm).
We also measured real-time concentrations of BC, SO2,
NO2, CO, and O3. Minute-to-minute BC concentration
was measured by Multi Angle Absorption Photometer
(MAAPModel 5012, Thermo Fisher Scientific Inc., USA).
Minute-to-minute SO2, NO2, CO, and O3 concentrations
were monitored by EC9800 Series Ambient Gas Analyzers
(Eco Tech Pty. Ltd., Australia). Temperature (°C) and rela-
tive humidity (%) were measured by a Met One unit (Met
One Instruments Inc., USA).
Statistical analysis
We calculated descriptive statistics for each air pollu-
tionmeasurement. Spearman correlations were calculated
across minute-to-minute data of air pollutants and mete-
orologic parameters. All HRV variables were logarith-
mically transformed using base 10 due to right skewed
distributions.
We first built basic generalized linear mixed models
with each HRV metric as the dependent variable. Based
on the assessment of Akaikes information Criterion (AIC),
we chose to model the temperature and RH using natu-
ral splines with degree of freedom up to 3, and modeled
time of the day using quadratic polynomial functions.
The first-order autoregressive model (AR1) was chosen
to account for intra-subject correlation within each visit
between repeated measures after comparison of several
covariance structures, based on the criteria of minimiz-
ing AIC. The effect of uncontrolled features of subjects
wasmodeled by random coefficient relying on subjects’ id.
Models were also adjusted for potential confounders such
as day of week, age, gender, BMI and visit.
Single-pollutant models were then developed by includ-
ing pollutant variables to examine the associations
between air pollution exposure and HRV measures. The
effects of particles in all size-fractions and other pollu-
tants under 1-, 4-, 12-, 18-, and 24-hour moving averages
were examined. Due to relatively high correlation between
concentration of particles and other air pollutants, we
conducted two-pollutant analyses by including the second
pollutant of prior 4-hour average exposure to examine the
robustness of the estimates associated with particles.
To evaluate potential effect modification by status of
disease and other factors, we conducted the analysis of
SDNN with each air pollutant using the 4-hour averaging
exposure, stratified by diabetic state (T2D vs. IGT), obe-
sity (Group 1, BMI≤25; Group 2, 25≤ BMI ≤28; Group 3,
28≤BMI), central adiposity (WHr), and gender, control-
ling the same covariates as in main models. We examined
the heterogeneity in the association estimates across strata
at the .05 significance level.
All effect estimates were expressed as percent change in
each HRV variable for interquartile range (IQR) increase
of the corresponding moving average of each pollutant,
calculated as [ 10(β×IQR) − 1]×100, with 95% confidence
intervals (CI) {10[IQR×(β∓1.96×SE)] −1}×100, where β and
SE are the estimated regression coefficient and its stan-
dard error. All analyses were conducted in SAS statistical
software (Version 9.2; SAS Institute; Cary, NC).
Additional files
Additional file 1: Description and correlations. This file contains 2
sheets. One is named ‘description_of_pollutants’, which is the extension of
Table 2, with basic descriptive statistics of surface concentration (PSC) and
mass concentration (PMC) of particles. The numbers after PSC or PMC
indicate the size fraction of particles. Another sheet is named
‘correlations_among_pollutants’, which is an extension of Table 3, with
correlations between surface or mass concentration of particles in each
size fraction, and BC, gaseous pollutants and meteorologic parameters. T
for temperature and * indicates correlation coefficients >0.6.
Additional file 2: Per IQR change single pollutant. This file contains 26
sheets. The name of the sheet gives the pollutant whose effect is shown in
it, and the numbers after PNC, PMC or PSC indicate the size fraction of
particles. Each sheet shows the percent change of all 5 HRV metrics, SDNN,
rMSSD, LF, HF and LF/HF, in response to the IQR increases in 1-. 4-, 12-, 18-,
and 24-hour moving averaged exposure to air pollutants. The column
‘Yvar’ indicates the HRV metric and the second column label the moving
average. The column ‘Per IQR ↑’ shows the percent change of the HRV
metric, and the columns ‘95% CI-Low’ and ‘95% CI-High’ give the lower and
upper bounds of 95% confidence interval.
Additional file 3: Per IQR change two pollutant. This file contains 1
sheet. It shows the effects of different metrics of particles on SDNN when
another gaseous pollutant or BC is also included in the model. The time
window for all pollutants is 4 hours prior to the HRV observation. The
column ‘Confound Pol’ indicates which pollutant is included in the model
to detect confounding effect. The column ‘Effect Pol’ indicates which
pollutant is potentially confounded. The numbers after PNC, PMC or PSC
indicate the size fraction of particles. The column ‘Per IQR ↑’ shows the
percent change of SDNN, and the columns ‘95% CI-Low’ and ‘95% CI-High’
give the lower and upper bounds of 95% confidence interval.
Additional file 4: Per IQR change stratified. This file contains 5 sheets.
Each sheet shows the modification effect of a factor discussed in this study.
The ratio of waist to hip circumference (WHr) is analyzed within each
gender due to different classification criteria. We only considered the effect
on SDNN and pollutants under prior 4-hour moving average for gender,
BMI and WHr. For the modification effect of diabetic state, we analyzed
both 4-hour and 24-hour time window. The group label is given in the first
row of each sheet. The numbers after PNC, PMC or PSC indicate the size
fraction of particles. The column ‘Per IQR ↑’ shows the percent change of
SDNN within each group, and the columns ‘95% CI-Low’ and ‘95% CI-High’
give the lower and upper bounds of 95% confidence interval.
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